Peer review Peer review information Nature Medicine thanks the anonymous reviewers for their contribution to the peer review of this work
1 Several factors can cause reduced GLP-1 secretion, including overweight and obesity, sleep deprivation, chronic stress, and certain gut conditions, leading to significant dysregulation of appetite, insulin sensitivity, glucose regulation, and even cardiovascular and neurological processes
Because retatrutide is investigational and not FDA approved, licensed pharmacies cannot legally compound or dispense it
These are usually mild and self-limiting
Trends in worldwide asthma prevalence
Rushing this process creates unnecessary side effects and increases the likelihood of discontinuation